Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

By R. Sears, Faison J. Nuckolls, Eric B. Haura, Y. Taya, K. Tamai, Joseph R. Nevins. Genes & Development, 2000

1,381 citations recorded by the source corpus.

Our recent work has shown that activation of the Ras/Raf/ERK pathway extends the half-life of the Myc protein and thus enhances the accumulation of Myc activity. We have extended these observations by investigating two N-terminal phosphorylation sites in Myc, Thr 58 and Ser 62, which are known to be regulated by mitogen stimulation. We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK. Conversely, phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc. Further analysis demonstrates that the Ras-dependent PI-3K pathway is also critical for controlling Myc protein accumulation, likely through the control of GSK-3 activity. These observations thus define a synergistic role for multiple Ras-mediated phosphorylation pathways in the control of Myc protein accumulation during the initial stage of cell proliferation.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/543e9204fe639d76634cc6300f74baf2e6b511aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

Citations in the corpus

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. (2007, methodology): “We retrovirally infected female mouse embryonic fibroblasts (MEFs) carrying a GFP-IRES-puro cassette in the endogenous Nanog locus, referred to as Nanog-GFP (Hatano et al., 2005), with cDNAs encoding Oct4, Sox2, c-MYC (T58A mutant, which stabilizes the protein) ( Sears et al., 2000 ), and Klf4.”
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7 (2004, background): “Immunoprecipitation with antibodies to c-Myc and subsequent immunoblot analysis with antibodies to HA, c-Myc, or phospho-c-Myc revealed that HA-Fbw7 was co-precipitated only with c-Myc that was phosphorylated by GSK3 (Figure 3E).”
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. (2006, background): “, 1996), MYC (Sears et al., 2000), cyclin D1 (Diehl et al.”
Neuroblastoma and MYCN (2013, positive): “4) (Sears et al. 2000; Welcker et al. 2004; Yada et al. 2004).”
GSK-3: tricks of the trade for a multi-tasking kinase (2003, background): “One of the pathways regulated by Wnt molecules is termed the canonical Wnt pathway or the Wnt/β-catenin pathway (reviewed in Huelsken and Behrens, 2002; Polakis, 2000; Seidensticker and Behrens, 2000; Sharpe et al., 2001) (Fig.”
The RSK family of kinases: emerging roles in cellular signalling (2008, background): “GSK3 phosphorylates cyclin D1 and MYC, which targets these proteins for degradatio”
P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation (2008, positive): “It is also notable that both p53 and Pten/PI3K pathways can directly regulate c-Myc with p53 repressing c-MYC transcription through direct binding to c-MYC promoter 23 , while downstream PI3K pathway arms can modulate c-MYC translation and protein degradation 24, 25 .”
The Ras-ERK and PI3K-mTOR Pathways: Cross-talk and Compensation (2011, neutral): “ERK-mediated phosphorylation of Ser62 stabilizes c-Myc [46].”
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells (2004, background): “Ras promotes stability of c-Myc through at least two effector pathways: the Raf–MEK–ERK kinase cascade, and the phosphatidylinositol-3-OH kinase (PI(3)K)–Akt pathway that inhibits glycogen synthase kinase-3β (GSK-3β”